The timing of initiation of pharmacotherapy for women with gestational diabetes mellitus.
Rachel K HarrisonMeredith CruzAshley WongCaroline DavittAnna PalatnikPublished in: BMC pregnancy and childbirth (2020)
Initiation of pharmacotherapy for GDM when 20-39% of CBG values are above goal, compared to ≥40%, was associated with decreased rates of adverse neonatal outcomes attributable to GDM. This was accompanied by higher rates of SGA among women receiving pharmacotherapy at the lower threshold. Additional studies are required to identify the optimal threshold of abnormal CBG values to initiate pharmacotherapy for GDM.